Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 26, 2017 - Issue 6
Submit an article Journal homepage
895
Views
12
CrossRef citations to date
0
Altmetric
Review

Novel investigational drugs active as single agents in multiple myeloma

Mattia D’AgostinoMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, ItalyView further author information
,
Marco SalviniMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, ItalyView further author information
,
Antonio PalumboMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy;Currently Takeda employeeView further author information
,
Alessandra LaroccaMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, ItalyView further author information
&
Francesca GayMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, ItalyCorrespondence[email protected]
View further author information
Pages 699-711 | Received 17 Feb 2017, Accepted 25 Apr 2017, Published online: 08 May 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Francesca Bonello, Mattia D’Agostino, Maria Moscvin, Chiara Cerrato, Mario Boccadoro & Francesca Gay. (2018) CD38 as an immunotherapeutic target in multiple myeloma. Expert Opinion on Biological Therapy 18:12, pages 1209-1221.
Read now

Articles from other publishers (11)

Zhaoyun Liu, Yunhe Zhang, Yixuan Guo, Hao Wang & Rong Fu. (2023) An overview of pim kinase as a target in multiple myeloma. Cancer Medicine 12:10, pages 11746-11759.
Crossref
Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M. Poos, Britta Besemer, Kaya Miah, Axel Benner, Nicole Becker, Thomas Moehler, Ivana Metzler, Cyrus Khandanpour, Andrea Seidel-Glaetzer, Karolin Trautmann-Grill, K. Martin Kortüm, Carsten Müller-Tidow, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Niels Weinhold, Hartmut Goldschmidt, Katja Weisel & Marc S. Raab. (2023) A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAF V600E-mutated multiple myeloma . Blood 141:14, pages 1685-1690.
Crossref
Daniele Derudas & Claudia Concu. 2023. Recent Updates on Multiple Myeloma. Recent Updates on Multiple Myeloma.
Chunjuan Lu & Jin Wei. (2022) SIRT2-KLF4 Interactions are Critical for Myeloma Survival and Migration. Computational Intelligence and Neuroscience 2022, pages 1-6.
Crossref
Konstantin Byrgazov, Andrej Besse, Marianne Kraus, Ana Slipicevic, Fredrik Lehmann, Christoph Driessen & Lenka Besse. (2021) Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells. HemaSphere 5:7, pages e602.
Crossref
Alessandro Allegra, Vanessa Innao, Francesca Polito, Rosaria Oteri, Angela Alibrandi, Andrea Gaetano Allegra, Giacomo Oteri, Rosa Maria Di Giorgio, Caterina Musolino & M'hammed Aguennouz. (2021) SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma. Clinical Biochemistry 93, pages 42-49.
Crossref
Cecilia Bonolo de Campos, Nathalie Meurice, Joachim L. Petit, Alysia N. Polito, Yuan Xiao Zhu, Panwen Wang, Laura A. Bruins, Xuewei Wang, Ilsel D. Lopez Armenta, Susie A. Darvish, Greg J. Ahmann, Kimberly J. Henderson, Shulan Tian, Jonas J. Kruse, William M. Stewart, Jeremy T. Larsen, Craig B. Reeder, David Dingli, Prashant Kapoor, Shaji K. Kumar, Rafael Fonseca, P. Leif Bergsagel, Esteban Braggio & A. Keith Stewart. (2020) “Direct to Drug” screening as a precision medicine tool in multiple myeloma. Blood Cancer Journal 10:5.
Crossref
Mattia D’Agostino, Giulia Gazzera, Giusy Cetani, Sara Bringhen, Mario Boccadoro & Francesca Gay. (2019) Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma. Current Medicinal Chemistry 26:32, pages 5968-5981.
Crossref
Philip Vlummens, Kim De Veirman, Eline Menu, Elke De Bruyne, Fritz Offner, Karin Vanderkerken & Ken Maes. (2019) The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma. Frontiers in Genetics 10.
Crossref
Xia Cheng, Guoliang Zhang, Raina Seupel, Doris Feineis, Daniela Brünnert, Manik Chatterjee, Andreas Schlosser & Gerhard Bringmann. (2018) Epoxides related to dioncoquinone B: Synthesis, activity against multiple myeloma cells, and search for the target protein. Tetrahedron 74:38, pages 5102-5112.
Crossref
Philippe Moreau. (2017) How I treat myeloma with new agents. Blood 130:13, pages 1507-1513.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.